Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

被引：6

作者：

Fernandes, Caio J. C. S. ^{[1
,2
,3
]}

da Silva, Taysa A. F. ^{[1
]}

Alves Jr, Jose L. ^{[1
,2
,3
]}

Jardim, Carlos V. P. ^{[1
,3
]}

de Souza, Rogerio ^{[1
,3
]}

机构：

[1] Univ Sao Paulo, Heart Inst, Med Sch, Pulm Circulat Unity,Cardiopulmonol Dept, 44 Dr Eneas Carvalho Aguiar Av, BR-05403000 Sao Paulo, SP, Brazil

[2] Univ Sao Paulo, Med Sch, Canc Inst, Sao Paulo, Brazil

[3] Sirio Libanes Hosp, Sao Paulo, Brazil

来源：

PULMONARY CIRCULATION | 2021年 / 11卷 / 01期

关键词：

inhaled iloprost; sequential triple combination therapy; pulmonary arterial hypertension; hemodynamics; COMBINATION THERAPY; REGISTRY;

D O I：

10.1177/2045894020981350

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.

引用

页数：3

共 50 条

[41] Long-term therapy with inhaled iloprost in patients with pulmonary hypertension
Olschewski, Horst
Hoeper, Marius M.
Behr, Juergen
Ewert, Ralf
Meyer, Andreas
Borst, Mathias M.
Winkler, Joerg
Pfeifer, Michael
Wilkens, Heinrike
Ghofrani, Hossein Ardeschir
Nikkho, Sylvia
Seeger, Werner
[J]. RESPIRATORY MEDICINE, 2010, 104 (05) : 731 - 740
[42] Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
Yildirim, Sukran
[J]. PULMONARY CIRCULATION, 2023, 13 (03)
[43] Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
Samudro, Heru
Djer, Mulyadi M.
[J]. PAEDIATRICA INDONESIANA, 2012, 52 (01) : 57 - 60
[44] Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension
Ghofrani, HA
Wiedemann, R
Rose, F
Olschewski, H
Schermuly, RT
Weissmann, N
Seeger, W
Grimminger, F
[J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (07) : 515 - 522
[45] CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) AND INHALED ILOPROST THERAPY IN PREGNANCY
Horng, Michelle
Mohammad, Insaf
Smith, Zach
Awdish, Rana
Cajigas, Hector
[J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
[46] A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
Channick, Richard N.
Frantz, Robert P.
Kawut, Steven M.
Palevsky, Harold
Tumuluri, Ramagopal
Sulica, Roxana
Lauto, Paula O.
Benton, Wade W.
de Boisblanc, Bennett
[J]. PULMONARY CIRCULATION, 2013, 3 (02) : 381 - 388
[47] Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension
Barst, Robyn J.
Oudiz, Ronald J.
Beardsworth, Anthony
Brundage, Bruce H.
Simonneau, Gerald
Ghofrani, Hossein A.
Sundin, David P.
Galie, Nazzareno
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (06): : 632 - 643
[48] Treatment of severe pulmonary hypertension with inhaled iloprost
Leuchte, HH
Baumgartner, RA
Behr, J
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (04) : 306 - 306
[49] A Multicenter, Retrospective Study Of Patients With Pulmonary Arterial Hypertension Transitioned From Parenteral Prostacyclin Therapy To Inhaled Iloprost
Channick, R. N.
Frantz, R. P.
Kawut, S. M.
Palevsky, H.
Tumuluri, R.
Sulica, R.
Benton, W.
DeBoisblanc, B.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[50] INHALED ILOPROST FOR SARCOIDOSIS ASSOCIATED PULMONARY HYPERTENSION
Baughman, R. P.
Judson, M. A.
Lower, E. E.
Highland, K.
Kwon, S.
Craft, N.
Engel, P. J.
[J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2009, 26 (02) : 110 - 120

← 1 2 3 4 5 →